COVERSCAN STUDY
COVERSCAN STUDYCOVERSCAN STUDYCOVERSCAN STUDYMapping how COVID-19 impacts the health of multiple organs
Contact us on coverscan@perspectum.com or +44 (0) 1865 655 024
COVERSCAN STUDY
COVERSCAN STUDYCOVERSCAN STUDYCOVERSCAN STUDYMapping how COVID-19 impacts the health of multiple organs
Contact us on coverscan@perspectum.com or +44 (0) 1865 655 024
Welcome
Perspectum has launched the first study to map how COVID-19 impacts the health of multiple organs and identify at-risk features for the virus, with detailed cross-sectional imaging and genetic studies.
This study is: High Priority COVID-19 Urgent Public Health Research.
Clinical Trials Identifier: NCT04369807
About COVERSCAN
Aims
Which organs will be assessed?
Which organs will be assessed?
To determine the prevalence and degree of organ damage in patients recovering from COVID-19 disease, using multi-parametric magnetic resonance imaging (MRI).
Which organs will be assessed?
Which organs will be assessed?
Which organs will be assessed?
- Lungs
- Heart
- Kidney
- Liver
- Pancreas
- Spleen
How will they be assessed?
Which organs will be assessed?
How will they be assessed?
The study will use outpatient MRI facilities and involve blood tests, basic physical measurements (height, weight, blood pressure) and online questionnaires.
Locations
Oxford
Oxford
Oxford
Gemini One
5520 John Smith Dr, Oxford OX4 2LL, United Kingdom
London
Oxford
Oxford
Mayo Clinic (Healthcare)
15 Portland Pl, Marylebone, London W1B 1PT, United Kingdom
Copyright © 2020 Perspectum - All Rights Reserved.
Powered by GoDaddy Website Builder